Nasonov, E. L., & Feist, E. The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6). IMA PRESS LLC.
Chicago Style (17th ed.) CitationNasonov, E. L., and E. Feist. The Prospects of Interleukin-6 Inhibition in Rheumatoid Arthritis: Olokizumab (novel Monoclonal Antibodies to IL-6). IMA PRESS LLC.
MLA (9th ed.) CitationNasonov, E. L., and E. Feist. The Prospects of Interleukin-6 Inhibition in Rheumatoid Arthritis: Olokizumab (novel Monoclonal Antibodies to IL-6). IMA PRESS LLC.
Warning: These citations may not always be 100% accurate.